| Basics |
VolitionRX Limited Common Stock
VolitionRX Ltd is a clinical-stage life sciences company. The company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
|
| IPO Date: |
April 1, 2012 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$67.17M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 3.35%
|
| Avg Daily Range (30 D): |
$0.04 | 5.25%
|
| Avg Daily Range (90 D): |
$0.03 | 4.72%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.12M |
| Avg Daily Volume (30 D): |
.17M |
| Avg Daily Volume (90 D): |
.18M |
| Trade Size |
| Avg Trade Size (Sh.): |
232 |
| Avg Trade Size (Sh.) (30 D): |
358 |
| Avg Trade Size (Sh.) (90 D): |
386 |
| Institutional Trades |
| Total Inst.Trades: |
12 |
| Avg Inst. Trade: |
$2.06M |
| Avg Inst. Trade (30 D): |
$.68M |
| Avg Inst. Trade (90 D): |
$.68M |
| Avg Inst. Trade Volume: |
.63M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.26M |
| Avg Closing Trade (30 D): |
$.68M |
| Avg Closing Trade (90 D): |
$.68M |
| Avg Closing Volume: |
984.71K |
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
|
|
|
|
Diluted EPS
|
$-.06
|
|
$-.31
|
|
Revenue
|
$ .25M
|
$ .19M
|
$ 1.23M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -5.48M
|
$ -5.86M
|
$ -27.26M
|
|
Operating Income / Loss
|
$ -5.52M
|
$ -5.78M
|
$ -27.02M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -.66M
|
$ -2.15M
|
$ -17.47M
|
|
PE Ratio
|
|
|
|
|
|
|
